The proper period of anti-seizure medication (ASM) treamtment is important for decreasing side effect of ASM and recurrence of seizure. We evaluate reliable risk factor analysis for safe withdrawal of ASM in children with epilepsy. Futhermore, we develop the scoring system for prediction of seizure recurrence to set the standard for safe withdrawal of ASM.
The enroll criteria as follow:
1. patients with epilepsy or acute provoked seizure accroding to the ILAE definition
2. patients who have been 2 years of seizure free with or without ASM
The patients with seizure recurrence during follow-up or end of follow-up period of 24 months will end this stutdy.
Age
0–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with Epilepsy or acute provoked seizure according to the ILAE guideline
Patients with 2 years of seizure free periods
You may not be if
Uncertain diagnosis of epilepsy or acute provoked seizure
Patients who do not want to participate in the study
Clareo Health | Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy
